GALECTIN THERAPEUTICS INC Stock Agreements
11 Contracts & Agreements
- 2020 Deferred Stock Unit Amendment (Filed With SEC on July 26, 2022)
- 2023 Deferred Stock Unit Agreement (Filed With SEC on July 26, 2022)
- Deferred Stock Unit Agreement, dated August 31, 2020, between Galectin Therapeutics Inc. and Joel Lewis (Filed With SEC on September 2, 2020)
- GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001per share) At Market Issuance Sales Agreement (Filed With SEC on May 19, 2017)
- GALECTIN THERAPEUTICS INC. Common Stock (par value $0.001per share) At Market Issuance Sales Agreement (Filed With SEC on October 25, 2013)
- STOCK OPTION AGREEMENT GALECTIN THERAPEUTICS INC. STOCK OPTION AGREEMENT FOR THOMAS MCGAULEY AGREEMENT (Filed With SEC on August 14, 2013)
- PRO-PHARMACEUTICALS, INC. NON-QUALIFIED STOCK OPTION AGREEMENT FOR PETER G. TRABER, M.D. (Filed With SEC on March 9, 2011)
- PRO-PHARMACEUTICALS, INC. NON-QUALIFIED STOCK OPTION AGREEMENT (Filed With SEC on March 30, 2009)
- PRO-PHARMACEUTICALS, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on March 30, 2009)
- THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANYS PROSPECTUS DATED FEBRUARY , 2009 (THE PROSPECTUS) AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF... (Filed With SEC on February 2, 2009)
- [FORM OF NOTICE TO BENEFICIAL STOCKHOLDERS OF COMMON STOCK] PRO-PHARMACEUTICALS, INC. NOTICE TO CLIENTS OF STOCKHOLDERS WHO ARE ACTING AS NOMINEES Up to [ ] Shares of Common Stock... (Filed With SEC on February 2, 2009)
